362 results on '"Perova, N. V."'
Search Results
2. Moral Agency Conditions: Moral Agent, Limited Moral Agent, Quasi-Moral Agent
3. Experimental Study of the Effects of Nanodispersed Ceria on Wound Repair
4. A biomedical cell product for the regeneration of articular cartilage: Biocompatible and histomorphological properties (an experimental model of subcutaneous implantation)
5. Heat capacity and physical transitions in collagen and solubility of water in it
6. Association of serum apolipoprotein A-II concentration with combined hyperlipidemia and impaired glucose tolerance
7. Effect of a Single Fat Load on Major Hemostasis Parameters in Subjects with Different Types of Obesity
8. Hormonal Regulation of Lipid Metabolism in Healthy Subjects with or without Obesity
9. Polymorphic Variants of the Renin–Angiotensin System Genes in the Polymetabolic Syndrome and Non-Insulin-Dependent Diabetes Mellitus
10. Polymorphism of the Angiotensin-Converting Enzyme Gene in Patients with Coronary Heart Disease from the Moscow Population
11. Phospholipid Composition of High-Density Lipoproteins Reflects Lipolysis of Triglyceride-Rich Lipoproteins during Hyperlipidemia
12. Experimental in vitro Comparative Study of Chromovitectomy Agents Cyto- and Phototoxicity
13. Anti-tuberculosis activity in the presence of drug resistance as a rationale for prospect use of thiosonide
14. Effect of micronized fenofibrate (Lipanthyl-200M) on cholesterol synthesis in peripheral blood lymphocytes in hyperlipidemic patients with coronary heart disease
15. Parameters of high-density lipoproteins in patients with arterial hypertension in combination with other components of metabolic syndrome
16. Dynamics of formation of primary and secondary lipid peroxidation products upon copper-dependent oxidation of low-density lipoproteins isolated from blood serum of patients with ischemic heart disease
17. Impaired Antiatherogenic Function of High-Density Lipoproteins in the Presence of Various Risk Factors for Coronary Heart Disease
18. Simvastatin and Preparation of Polyunsaturated Phospholipids Produce Similar Changes in the Phospholipid Composition of High-Density Lipoproteins during Hypercholesterolemia
19. Peculiarities of changes in the rate of cholesterol synthesis in lymphocytes and lipid and lipoprotein peripheral blood levels in patients with ischemic heart disease and hypercholesterolemia in the course of combined treatment with lovastatin and obsidan
20. Effects of Simvastatin on the Phospholipid Composition of High-Density Lipoproteins in Patients with Hypercholesterolemia
21. Low-Density Lipoprotein Subfractions during Abdominal and Gluteofemoral Obesity
22. Cerivastatin modulates antiatherogenic properties of high-density lipoproteins in patients with coronary heart disease and hyperlipidemia
23. Effect of endur-acine on plasma activity of cholesterol ester transfer protein in subjects with hypercholesterolemia
24. Immunochemical detection of apoprotein dissociation from very low density lipoprotein particles in human blood plasma
25. The Role of Apoproteins in Determination of Atherogeneity or Antiatherogeneity of Blood Plasma Lipoproteins
26. Features of Composition and Structure of High Density Lipoproteins in Disulphatlipoproteinemias According to Spin Label Electron Paramagnetic Resonance Spectroscopy Data
27. Correlates of pulse wave velocity with risk factors for atherosclerotic cardiovascular diseases and diabetes mellitus
28. To lower trans fatty acid intake as an important condition for the reduction of cardiovascular mortality
29. Atheromarkers of high-density lipoproteins. Part II. Impairments in the composition, structure, and functions of high-density lipoproteins as both the cause of their atherogenic properties and their atheromarkers: a review of literature
30. Atheromarkers of high-density lipoproteins. Part 1. High-density lipoproteins: Structure, composition, physicochemical and physiological antiatherogenic properties, their mechanisms and markers (a review of literature)
31. Analysis of atherogenic dyslipidemias prevalence among population of Russian Federation (results of the ESSE-RF Study)
32. ASSESSMENT OF THE RELATION BETWEEN ARTERIAL STIFFNESS PARAMETERS AND ATHEROTHROMBOSIS FACTORS IN VARIOUS AGE GROUPS
33. SUBFRACTIONAL SPECTRUM OF HIGH DENSITY LIPOPROTEIDS IN CORONARY ATHEROSCLEROSIS PATIENTS
34. THE FUNCTIONAL EFFECTIVENESS OF A CELL-ENGINEERED CONSTRUCT FOR THE REGENERATION OF ARTICULAR CARTILAGE
35. VLDL substrate properties and efficiency of their metabolic transformation by LPL
36. Lipoprotein lipase and lecithin-cholesterol acyltransferase activity in experimentally modified lipoprotein metabolism
37. Number of glucocorticoid receptors in lymphocytes and their sensitivity to hormone action
38. INFLUENCE OF MICROSTRUCTURED COLLAGEN HYDROGEL ON PANCREATIC ISLET CELL CULTURES
39. RATIONAL APPROACHES TO THE TREATMENT OF DYSLIPIDEMIA WITH DIFFERENT TOTAL CARDIOVASCULAR RISK AND ACUTE CORONARY SYNDROME
40. FACTOR ANALYSIS AND INDIVIDUAL PROGNOSIS FOR THE PATIENTS WITH FIRST REVEALED ARTERIAL HYPERTENSION
41. LOW-DENSITY LIPOPROTEIN SUBFRACTIONS AND VARYING DEGREE OF CORONARY STENOSIS
42. Efficacy of a combination of cholesterol absorption and synthesis inhibitors in the correction of hyperlipidemia and dietary fat intolerance in patients with coronary heart disease (ESTHETICS trial)
43. ASSOCIATION BETWEEN THE DEGREE OF CORONARY ATHEROSCLEROSIS, RISK FACTORS, AND MARKERS OF CAROTID AND PERIPHERAL ARTERY ATHEROSCLEROSIS
44. EFFECT OF CHOLESTEROL BLOOD LEVEL REDUCTION BEGINNING EARLY IN LIFE ON THE RISK OF ISCHEMIC HEART DISEASE
45. Gender specifics of the association between blood fibrinolytic activity and cardiovascular disease or diabetes mellitus in a cohort of Muscovites aged 55 years or older
46. Plant sterols and stanols as dietary factors reducing hypercholesterolemia by inhibiting intestinal cholesterol absorption
47. REDUCTION DEGREE OF LOW-DENSITY LIPOPROTEINS CHOLESTEROL LEVELS ACCORDING TO DIFFERENT DOSES OF STATINS; ITS EFFECT ON THE RISK OF ISCHEMIC HEART DISEASE ACUTE EPISODES DEPENDING ON TREATMENT DURATION; AND RISK OF ISCHEMIC AND THROMBOEMBOLIC STROKE. COMMENT ON THE PAPER OF LAW M.R., WALD N.J., RUDNICKA A.R. QUANTIFYING EFFECT OF STATINS ON LOW DENSITY LIPOPROTEIN CHOLESTEROL, ISCHAEMIC HEART DISEASE, AND STROKE: SYSTEMATIC REVIEW AND META-ANALYSIS. BMJ 2003; 326:1423-1427
48. DIETARY FATTY ACIDS. EFFECTS ON THE RISK OF CARDIOVASCULAR DISEASES
49. EFFECT OF SIMVASTATIN ON MARKERS OF CARDIOVASCULAR RISK
50. Antiaterogennye effekty mikronizirovannogo fenofibrata pri metabolicheskom sindrome i sakharnom diabete 2 tipa
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.